Amsbio announce the availability of fresh whole blood products from diverse, healthy donors now with overnight delivery in the US, Europe and the UK in conjunction with sister company – Research Donors. All these premium human blood biospecimens undergo rigorous serology screening and rapid processing to ensure maximum viability.
Supplied with donor diversity data including age, sex, blood type and other characteristics, all fresh blood products come fully consented with compliance documentation for genetic analysis, biomarker discovery and commercial research.
Sourcing blood products for life science research can be daunting, especially when selecting the right anticoagulant for your study. Whether you are working with PBMCs, plasma, serum, leukopaks, buffy coats, isolated immune cells, or whole blood, choosing the correct anticoagulant is crucial to avoid interference in assays and to preserve sample integrity. Amsbio offers fresh blood biospecimens fully customisable to meet your research needs with a choice of anticoagulant (EDTA, heparin, citrate), collection device, delivery format, and timing.
To learn more about premium human blood biospecimens (both fresh and frozen) to advance research in immunology, diagnostics, drug development, and cell therapy innovation please visit https://www.amsbio.com/products/biorepository/biofluids or contact Amsbio on +31-72-8080244 / +44-1235-828200 / +1-617-945-5033 / [email protected].
Amsbio, part of the Europa Biosite group, is a leading life sciences company supporting drug discovery, translational research, and cell and gene therapy across Europe, North America, and wider international markets. With in depth expertise in advanced cell culture, 3D cell models, and cryopreservation, Amsbio is well placed to help researchers progress from early discovery through to clinical and GMP-ready applications. The company’s portfolio of innovative products and services supports multiple stages of the research pipeline, spanning target discovery, assay development, and disease modelling, through to stem cell and organoid-based research. Key solutions include the integrated stem call platform combining StemFit™ media, iMatrix™ recombinant laminins, and CELLBANKER™ cryopreservation technology, alongside extracellular matrix technologies, biospecimens, glycobiology tools, kits and assays, and a wide range of custom services including viral delivery. Drawing on extensive GMP expertise and a comprehensive human and animal biorepository, Amsbio is internationally recognized for delivering high-quality, application-ready products and services. Amsbio has a consistent record of close scientific collaboration with partners in academic, biotech, and pharmaceutical markets to translate innovation from bench to bedside.
